Conditions: Chronic Obstructive Pulmonary Disease (COPD)
Keywords: COPD Symbicort Seretide
Allocation: RANDOMIZED | Intervention model: CROSSOVER
Enrollment: 442
Healthy volunteers: no

Brief summary:
This study is to assess the effects with two different inhaled respiratory medications with regards to improvement of lung function, symptoms and morning activities.

Detailed description:

Arms:
arm 1: Symbicort Turbuhaler (budesonide/formoterol) 320/9 μg First, then Seretide Diskus (salmeterol/fluticasone) 50/500 μg arm 2: Seretide Diskus (salmeterol/fluticasone) 50/500 μg First, then Symbicort Turbuhaler (budesonide/formoterol) 320/9 μg

Interventions: intervention 1: Symbicort Turbuhaler (budesonide/formoterol) 320/9 μg intervention 2: Seretide Diskus (salmeterol/fluticasone) 50/500 μg
Intervention descriptions: intervention 1: None intervention 2: None

Protocol document: